ClinicalTrials.Veeva

Menu
O

Oklahoma Heart Hospital | Oklahoma Cardiovascular Research Group

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

PF-04950615
RN316
Apixaban
carvedilol
Clopidogrel
Deferiprone
INS50589
Tolvaptan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 25 total trials

Baroreflex Activation Therapy for Heart Failure (BeAT-HF)

The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therap...

Active, not recruiting
Heart Failure
Device: BAROSTIM NEO® System
Drug: Medical Management

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated he...

Enrolling
ADHF
Heart Failure, Diastolic
Device: Aortix System

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitati...

Enrolling
Tricuspid Valve Insufficiency
Tricuspid Valve Disease
Drug: Optimal Medical Therapy
Device: Edwards PASCAL System

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic...

Enrolling
Aortic Stenosis, Severe
Aortic Stenosis
Device: Edwards SAPIEN 3/SAPIEN 3 Ultra THV

To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis w...

Active, not recruiting
Aortic Stenosis
Procedure: SAVR
Device: SAPIEN 3 THV

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which a...

Active, not recruiting
Symptomatic Severe Aortic Stenosis
Device: TAVR

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease...

Active, not recruiting
Peripheral Vascular Disease
Femoropopliteal Artery Occlusion
Device: Medtronic IN.PACT Admiral DCB
Device: Surmodics SurVeil DCB

Trial sponsors

Edwards Lifesciences logo
C
Boston Scientific logo
Pfizer logo
Abbott logo
B
Bristol-Myers Squibb (BMS) logo
C
C
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems